Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes (Q38926789)

7 September 2017

1 reference

title

Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes (English)

1 reference

7 September 2017

main subject

cognitive dysfunction

1 reference

1 reference

type 2 diabetes

9 December 2023

Giovambattista De Sarro

5

object named as

Giovambattista De Sarro

0 references

author name string

Caterina Palleria

1

1 reference

7 September 2017

Christian Leporini

2

1 reference

7 September 2017

Francesca Maida

3

1 reference

7 September 2017

Elena Succurro

4

1 reference

7 September 2017

Giovambattista De Sarro

5

1 reference

7 September 2017

Franco Arturi

6

1 reference

7 September 2017

Emilio Russo

7

1 reference

7 September 2017

publication date

9 August 2016

1 reference

Frontiers in Neuroendocrinology

7 September 2017

published in

1 reference

7 September 2017

volume

42

1 reference

7 September 2017

page(s)

76-92

1 reference

The requirement of BDNF for hippocampal synaptic plasticity is experience-dependent

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Rosiglitazone and cognitive stability in older individuals with type 2 diabetes and mild cognitive impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Variations in tissue selectivity amongst insulin secretagogues: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL/6J mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Metformin Eased Cognitive Impairment Induced by Chronic L-methionine Administration: Potential Role of Oxidative Stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Standards of medical care in diabetes--2013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Risk profiles for mild cognitive impairment and progression to dementia are gender specific.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Cognitive enhancing effects of ghrelin receptor agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Exenatide and the treatment of patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Intrahippocampal insulin improves memory in a passive-avoidance task in male wistar rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Higher total ghrelin levels are associated with higher insulin-mediated glucose disposal in non-diabetic maintenance hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase/Akt-mediated mechanism that reduces the activation of caspase-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Intranasal insulin improves memory in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Hippocampal insulin resistance and cognitive dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Risk of dementia in diabetes mellitus: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Sirtuins in cognitive ageing and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Rapamycin reverses status epilepticus-induced memory deficits and dendritic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Biochemistry and molecular cell biology of diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

The pathobiology of diabetic complications: a unifying mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Brain imaging in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

An examination of early neural and cognitive alterations in hippocampal-spatial function of ghrelin receptor-deficient rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Risk factors for the progression of mild cognitive impairment to dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

SIRT1 and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Hyperglycemia, hypoglycemia and dementia: role of mitochondria and uncoupling proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

UCP2 and ANT differently modulate proton-leak in brain mitochondria of long-term hyperglycemic and recurrent hypoglycemic rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

7 January 2021

The many faces of CREB

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Ghrelin increases anxiety-like behavior and memory retention in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Involvement of PKA and ERK pathways in ghrelin-induced long-lasting potentiation of excitatory synaptic transmission in the CA1 area of rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Antidiabetic drugs restore abnormal transport of amyloid-β across the blood-brain barrier and memory impairment in db/db mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Local infusion of ghrelin enhanced hippocampal synaptic plasticity and spatial memory through activation of phosphoinositide 3-kinase in the dentate gyrus of adult rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Peroxisome proliferator-activated receptor gamma (PPAR-γ) and neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Insulin-like growth factor 1 is essential for normal dendritic growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Type 2 diabetes and late-onset Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Lixisenatide for type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Long Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Brain-derived neurotrophic factor serum levels correlate with cognitive performance in Parkinson's disease patients with mild cognitive impairment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Brain deletion of insulin receptor substrate 2 disrupts hippocampal synaptic plasticity and metaplasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Glucose levels and risk of dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer's prone mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Mutant mouse models of insulin-like growth factor actions in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Cognitive impairment and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Ghrelin controls hippocampal spine synapse density and memory performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

The role of mitochondrial uncoupling proteins in lifespan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Activation of sirtuin 1 attenuates cerebral ventricular streptozotocin-induced tau hyperphosphorylation and cognitive injuries in rat hippocampi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Insulin restores metabolic function in cultured cortical neurons subjected to oxidative stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3beta signaling pathways and changes in protein expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Favorable effects of vildagliptin on metabolic and cognitive dysfunctions in streptozotocin-induced diabetic rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Obesity, diabetes and cognitive deficit: The Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Glycaemic control: a balancing act or a different approach?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Ghrelin in central neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Peripheral hyperinsulinemia promotes tau phosphorylation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

A novel pathway regulates memory and plasticity via SIRT1 and miR-134

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Glucagon‐like peptide 1 modulates calcium responses to glutamate and membrane depolarization in hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Hippocampal Insulin Resistance Impairs Spatial Learning and Synaptic Plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Brain Insulin Administration Triggers Distinct Cognitive and Neurotrophic Responses in Young and Aged Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Evidence for abnormal glucose uptake or metabolism in thalamus during acute hyperglycaemia in type 1 diabetes--a 1H MRS study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Insulin promotes glycogen storage and cell proliferation in primary human astrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

CREB signalling regulates early survival, neuronal gene expression and morphological development in adult subventricular zone neurogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Adult mice maintained on a high-fat diet exhibit object location memory deficits and reduced hippocampal SIRT1 gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

The Role of GLP-1 in Neuronal Activity and Neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

The Physiology of Glucagon-like Peptide 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Incidence of Dementia is Increased in Type 2 Diabetes and Reduced by the Use of Sulfonylureas and Metformin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

The effect of constitutive over-expression of insulin-like growth factor 1 on the cognitive function in aged mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Effects of metformin on the cerebral metabolic changes in type 2 diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Central insulin-like growth factor-1 (IGF-1) restores whole-body insulin action in a model of age-related insulin resistance and IGF-1 decline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Metformin normalizes type 2 diabetes-induced decrease in cell proliferation and neuroblast differentiation in the rat dentate gyrus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Peroxisome proliferators reduce spatial memory impairment, synaptic failure, and neurodegeneration in brains of a double transgenic mice model of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Insulin receptor substrate 2 is a negative regulator of memory formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Glucagon-like peptide-1 protects synaptic and learning functions from neuroinflammation in rodents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

PPARγ agonist pioglitazone reverses memory impairment and biochemical changes in a mouse model of type 2 diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Sirtuin 1 overexpression mice show a reference memory deficit, but not neuroprotection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Central activation of PPAR-gamma ameliorates diabetes induced cognitive dysfunction and improves BDNF expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Pharmacophore modeling, homology modeling, and in silico screening reveal mammalian target of rapamycin inhibitory activities for sotalol, glyburide, metipranolol, sulfamethizole, glipizide, and pioglitazone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Diabetes mellitus: The epidemic of the century

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Functional roles of CREB as a positive regulator in the formation and enhancement of memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Insulin action in brain regulates systemic metabolism and brain function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Cognitive disorders in diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Ghrelin--a hormone with multiple functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

DPP-4 Inhibitor Linagliptin Attenuates Aβ-induced Cytotoxicity through Activation of AMPK in Neuronal Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

GLP-1 and exendin-4 transiently enhance GABAA receptor-mediated synaptic and tonic currents in rat hippocampal CA3 pyramidal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Therapeutic use of agonists of the nuclear receptor PPARgamma in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Regulation of hippocampal synaptic plasticity by BDNF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Hypoglycemia induces tau hyperphosphorylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Lixisenatide improves recognition memory and exerts neuroprotective actions in high-fat fed mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

(Val(8))GLP-1-Glu-PAL: a GLP-1 agonist that improves hippocampal neurogenesis, glucose homeostasis, and β-cell function in high-fat-fed mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Adherence to therapy and adverse drug reactions: is there a link?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Ghrelin directly stimulates adult hippocampal neurogenesis: implications for learning and memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Liraglutide Promotes Cortical Neurite Outgrowth via the MEK-ERK Pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

An Update on Type 2 Diabetes Mellitus as a Risk Factor for Dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Intracerebroventricular infusion of insulin-like growth factor-I ameliorates the age-related decline in hippocampal neurogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Pioglitazone ameliorates memory deficits in streptozotocin-induced diabetic mice by reducing brain β-amyloid through PPARγ activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Insulin induces neurite outgrowth via SIRT1 in SH-SY5Y cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

The insulin signalling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Do men develop type 2 diabetes at lower body mass indices than women?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Function and regulation of CREB family transcription factors in the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

BDNF and synaptic plasticity, cognitive function, and dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Sex differences in the impact of diabetes on the risk of geriatric conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Relation of diabetes to mild cognitive impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Systemic insulin‐like growth factor‐I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning/memory in normal adult rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Early intervention with glucagon-like peptide 1 analog liraglutide prevents tau hyperphosphorylation in diabetic db/db mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Rosiglitazone improves learning and memory ability in rats with type 2 diabetes through the insulin signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Ghrelin-Attenuated Cognitive Dysfunction in Streptozotocin-induced Diabetic Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Glucagon-like peptide-1 cleavage product GLP-1(9-36) amide rescues synaptic plasticity and memory deficits in Alzheimer's disease model mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Intranasal Insulin Improves Age-Related Cognitive Deficits and Reverses Electrophysiological Correlates of Brain Aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

IRS-2 Deficiency Impairs NMDA Receptor-Dependent Long-term Potentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Incidence and survival of dementia in a general population of Japanese elderly: the Hisayama study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis, and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Exenatide twice daily: a review of its use in the management of patients with type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

The mechanisms that underlie glucose sensing during hypoglycaemia in diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Effect of gender on treatment outcomes in type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Effects of the glucagon-like polypeptide-1 analogue (Val8)GLP-1 on learning, progenitor cell proliferation and neurogenesis in the C57B/16 mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

CREB in adult neurogenesis--master and partner in the development of adult-born neurons?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

SIRT1 is essential for normal cognitive function and synaptic plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Ghrelin regulates hippocampal neurogenesis in adult mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Increased risk of cognitive impairment in patients with diabetes is associated with metformin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Brain-Wide Insulin Resistance, Tau Phosphorylation Changes, and Hippocampal Neprilysin and Amyloid-β Alterations in a Monkey Model of Type 1 Diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Executive functions and information processing in patients with type 2 diabetes in comparison to pre-diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Long-term metformin usage and cognitive function among older adults with diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Exendin-4 promotes the membrane trafficking of the AMPA receptor GluR1 subunit and ADAM10 in the mouse neocortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Glimepiride protects neurons against amyloid-β-induced synapse damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Pathways involved in the generation of reactive oxygen and nitrogen species during glucose deprivation and its role on the death of cultured hippocampal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Diabetes drugs and neurological disorders: new views and therapeutic possibilities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Early diagnosis of Alzheimer's disease: is MCI too late?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Chronic BDNF deficiency leads to an age-dependent impairment in spatial learning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

The role of insulin receptor signaling in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Intranasal insulin improves cognition and modulates beta-amyloid in early AD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Adipose tissue inflammation: feeding the development of type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Dipeptidyl peptidase-4 inhibitors have protective effect on cognitive impairment in aged diabetic patients with mild cognitive impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Association of diabetes with amnestic and nonamnestic mild cognitive impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

(Pre)diabetes, brain aging, and cognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Improving metabolic control leads to better working memory in adults with type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Role for neuronal insulin resistance in neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Insulin receptors and insulin action in the brain: review and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Gender differences in the relationship between diabetes process of care indicators and cardiovascular outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Exenatide reduces TNF-α expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Effects of type 2 diabetes on 12-year cognitive change: results from the Maastricht Aging Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Differential NMDA receptor-dependent calcium loading and mitochondrial dysfunction in CA1 vs. CA3 hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Cognitive function, dementia and type 2 diabetes mellitus in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Protein deacetylase SIRT1 in the cytoplasm promotes nerve growth factor-induced neurite outgrowth in PC12 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Hypoglycemia, brain energetics, and hypoglycemic neuronal death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Cognitive and functional influences of vildagliptin, a DPP-4 inhibitor, added to ongoing metformin therapy in elderly with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Hyperphosphorylation of Tau induced by naturally secreted amyloid-β at nanomolar concentrations is modulated by insulin-dependent Akt-GSK3β signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

A high calorie diet causes memory loss, metabolic syndrome and oxidative stress into hippocampus and temporal cortex of rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Intensive glycaemic control and cognitive decline in patients with type 2 diabetes: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Risk of developing dementia in people with diabetes and mild cognitive impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Insulin-like growth factor-1 receptor-mediated inhibition of A-type K( ) current induces sensory neuronal hyperexcitability through the phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2 pathways, independently of Akt.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Risk of Alzheimer's disease in relation to diabetes: a population-based cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Hypoglycaemia and cognitive function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

The association of duration of type 2 diabetes with cognitive performance is modulated by long-term glycemic control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Association of diabetes mellitus and mild cognitive impairment in middle-aged men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Insulin promotes rat retinal neuronal cell survival in a p70S6K-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Insulin resistance-induced hyperglycemia decreased the activation of Akt/CREB in hippocampus neurons: Molecular evidence for mechanism of diabetes-induced cognitive dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Effects of insulin-like growth factor 1 on synaptic excitability in cultured rat hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Alogliptin, a dipeptidylpeptidase-4 inhibitor, for patients with diabetes mellitus type 2, induces tolerance to focal cerebral ischemia in non-diabetic, normal mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Subcutaneous administration of liraglutide ameliorates Alzheimer-associated tau hyperphosphorylation in rats with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Myelination is altered in insulin-like growth factor-I null mutant mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Increasing CREB Function in the CA1 Region of Dorsal Hippocampus Rescues the Spatial Memory Deficits in a Mouse Model of Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Reduced cell proliferation and neuroblast differentiation in the dentate gyrus of high fat diet-fed mice are ameliorated by metformin and glimepiride treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Neuroprotection of insulin against oxidative stress-induced apoptosis in cultured retinal neurons: involvement of phosphoinositide 3-kinase/Akt signal pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Metformin protects against seizures, learning and memory impairments and oxidative damage induced by pentylenetetrazole-induced kindling in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Permissive role of insulin in the expression of long-term potentiation in the hippocampus of immature rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Role of insulin and insulin receptor in learning and memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Insulin and the insulin receptor in experimental models of learning and memory.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

Ghrelin administration enhances neurogenesis but impairs spatial learning and memory in adult mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YFRNE.2016.07.002

10.1016/J.YFRNE.2016.07.002

7 January 2021

Identifiers

DOI

1 reference

7 September 2017

1 reference